Commentary|Articles|August 9, 2023
Importance of DCTs Moving Forward
Perceived barriers of DCTs can be quickly overcome to ensure their viability in clinical research.
Advertisement
In this interview from DIA 2023, Janice Chang, CEO of TransCelerate BioPharma, discusses the unique opportuntities presented by decentralized clinical trials (DCTs).
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
2026 DIA Global Annual Meeting: What Drives Sponsors to Mixed Outsourcing Models and What the Transition Looks Like
2
Tapping the Global Potential of China’s Biotech Surge
3
2026 DIA Global Annual Meeting: How DCT Models Are Changing Recruitment and Retention for Sponsors
4
2026 DIA Global Annual Meeting: Why Protocol Digitization Has Been So Hard to Automate—Until Now
5